Since the disappearance of DMAA the pre-workout and fat burner market has been waiting for the perfect alternative and finally it has arrived in the form of GIANT RUSH™.
GIANT RUSH™ is a simple but effect super potent thermogenic that can be used during the day to boost energy, mood and control appetite or it can be used in a higher dose as the super stimulant base of a pre-workout. GIANT RUSH™ contains 3 ingredients that combine to give you enhanced energy, intense focus, super powered strength and a significant boost in your metabolism while controlling your appetite.
You can’t have a stimulant based pre workout without caffeine, and GIANT RUSH™ is no exception. 200mg is a nice dose that should be more than enough for most people. Kept in the right ratio with Kigelia Africana this dose of caffeine will provide immediate and sustained performance and energy. Caffeine has a pronounced ability to boost your metabolism. However, the biggest issue is desensitization. A lot of users become less responsive to caffeine the more they use. Fortunately Kigelia Africana has the ability to not only stimulate adrenalin it also enhances your responsiveness therefore boosting the benefit of caffeine.
Kigelia Africana (125mg)
Kigelia Africana (DMHA or 1,6-Dimethylhexylamine or 2-Aminoisoheptane) is so similar in structure and performance to DMAA its scary. In fact if anything it has some benefits that make it even more attractive from a performance and health perspective. DMHA was first discovered in the 1940’s and several studies were published on its efficacy and safety. (1,2,3,4,5).
Some of the benefits noted from users of DMHA are…
• Increased Energy and Motivation
• Increased Focus
• Improved Memory
• Increased Strength
• Elevated Mood
• Sense of Euphoria
• Controlled Appetite
• Enhanced Thermogenesis
• Clean Feel with No Crash
Bai Mudan™ (25mg)
This patented white tea (Bai Mudan™) has been standardized for theophylline. This unique amino acid has the ability to enhance energy and euphoria very rapidly. In fact before you finish your 300ml drink of GIANT RUSH™ you will feel a warm fuzzy feeling of happiness that soon shifts up a gear into intense energy and focus. Theophylline also helps to enhance the thought process and boost memory and reduce brain fog. Therefore, you can expect to be the sharpest tool in the box. This unique characteristic helps put GIANT RUSH™ into another category (Mental Clarity) for Gamers, Students, Shift Workers and Programmers.
GIANT RUSH™ is already becoming the most talked about super potent thermogenic stimulant on the market. The no anxiety, no shakes, no crash feeling on GIANT RUSH™ is simply one that can be described as Super Human.
Keep in mind that Giant Rush™ is a stimulant and should be used with caution. You should never use it with other stimulants and always check with your health care provider before using any new supplements. Although not specifically on the WADA banned list due to its similar structure to many other WADA listed compounds you should express caution and check with your governing body before starting supplementation.
PLEASE SEE IMAGES FOR NUTRITIONAL PANEL
Hutcheon, D, McCullough, L; “The Respiratory Stimul ant Action of Octylamines”; British Journal of Pharm acology; 7, 42; 1952; Retrieved from http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5 381.1952.tb00688.x/pdf
Charlier, R; “Pharmacology of 2-amino-6-methyl-hept ane”; Archives internationales de pharmacodynamie et de theɴrapie; 85(1-2):144-51; January 1951; Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/14820395
Fellows, E; “The pharmacology of 2-amino-6-methylhe ptane”; The Journal of pharmacology and experimental therapeutics; 90(4):351-8; August 1947; Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20265812
Fellows, E; “The pharmacology of 2-amino-6-methylhe ptane”; The Journal of pharmacology and experimental therapeutics; 90(4):351-8; August 1947; Retrieved from http://jpet.aspetjournals.org/content/90/4/351.abst ract
Fellows, E; “The pharmacology of 2-amino-6-methylhe ptane”; The Journal of pharmacology and experimental therapeutics; 90(4):351-8; August 1947; Retrieved from http://www.webcitation.org/6edUQGu7m